IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Horizon Pharma Plc.

CUSIP: 00BQPVQZ6 | 4 institutional holders

Quarters

Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2023

DnB Asset Management AS36,794
0.0% of portfolio›$4.3M
StyleTurnoverLocationFiled
DnB Asset Management AS
36,794$4.3M0.0%CoreMediumOslo, Norway2023-10-13